Extended Longevity

Extended Longevity is a private Hawaii-based longevity and wellness company developing and selling phytotherapeutic formulations aimed at supporting healthy aging. The company describes its approach as "Chronobiological Longevity Engineering" and markets a protocol of 10 formulations designed to address biological drivers of aging such as circadian regulation, thymic involution, telomere attrition, inflammaging, mitochondrial dysfunction, and epigenetic change. Public company materials indicate it has completed an internal clinical study, called Longevinaut Study #1, evaluating biomarker changes in healthy older adults, and it has promoted those results in connection with its anti-aging positioning. Based on currently available information, Extended Longevity appears to operate more as a longevity-focused phytotherapeutic and nutraceutical developer than as a conventional drug-development biotech with named regulated therapeutic assets in formal clinical phases.